Currently out of the existing stock ratings of Daniel Cardenas, 36 are a BUY (90%), 4 are a HOLD (10%).

Daniel Cardenas

Work Performance Price Targets & Ratings Chart

Analyst Daniel Cardenas, currently employed at JANNEY, carries an average stock price target met ratio of 85.74% that have a potential upside of 25.34% achieved within 459 days. Previously, Daniel Cardenas worked at RAYMOND JAMES.

Daniel Cardenas’s has documented 80 price targets and ratings displayed on 9 stocks. The coverage is on the Financial Services sector.

Most recent stock forecast was given on MBIN, Merchants Bancorp at 08-Jan-2025.

Wall Street Analyst Daniel Cardenas

Analyst best performing recommendations are on CASH (META FINANCIAL GROUP).
The best stock recommendation documented was for CASH (META FINANCIAL GROUP) at 10/29/2020. The price target of $33 was fulfilled within 12 days with a profit of $4.68 (16.53%) receiving and performance score of 13.77.

Average potential price target upside

CASH Meta Financial Group CSTR Capstar Financial Holdings FMNB Farmers National Banc Corp QCRH QCR Holdings SMBK SmartFinancial FSB Franklin Financial Network MBIN Merchants Bancorp FCF First Commonwealth Financial TSC TriState Capital Holdings

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$94

$22.1 (30.74%)

$91

7 months 21 days ago
(23-Apr-2025)

13/16 (81.25%)

$15.15 (19.21%)

361

Hold

$58

$-13.9 (-19.33%)

$60

1 years 8 months 9 days ago
(05-Apr-2024)

7/7 (100%)

$8.17 (16.40%)

134

Buy

$48

$-23.9 (-33.24%)

$55

3 years 4 months 16 days ago
(28-Jul-2022)

24/24 (100%)

$14.41 (42.90%)

447

Buy

$46

$-25.9 (-36.02%)

$70

3 years 5 months 7 days ago
(07-Jul-2022)

4/4 (100%)

$5.64 (13.97%)

384

Buy

$70

$-1.9 (-2.64%)

$68

4 years 1 months 16 days ago
(28-Oct-2021)

7/7 (100%)

$15.74 (29.01%)

480

Show more analysts

Please expand the browser size to see the chart

What Year was the first public recommendation made by Daniel Cardenas?

On 2013

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?